Literature DB >> 11238228

Use of formalin-fixed, propidium iodide-stained human leukocytes as a standard for enumerating CD4+ T lymphocytes in a single-platform assay.

G M Harrison1, A J Bennett, M Moody, G F Read, P E Williams.   

Abstract

A new, inexpensive method is described that enables lymphocytes to be enumerated very precisely. Normal leukocytes were simultaneously stained and fixed with a propidium iodide-paraformaldehyde solution. The preparation obtained (CellBeads) was used as an internal standard for cell enumeration by flow cytometry and was stable at 4 degrees C for at least 60 days. Unlike synthetic beads, the CellBeads behaved similarly to normal cells during red blood cell lysis and cell washing procedures. When known numbers of CellBeads were added to whole-blood samples and the numbers of CellBeads and lymphocytes were determined, highly reproducible and accurate enumerations were obtained-far more so than when synthetic beads were used. This inexpensive method is suitable for routine use.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11238228      PMCID: PMC96069          DOI: 10.1128/CDLI.8.2.397-401.2001

Source DB:  PubMed          Journal:  Clin Diagn Lab Immunol        ISSN: 1071-412X


  10 in total

1.  Enumeration of CD4(+) T-cells in the peripheral blood of HIV-infected patients: an interlaboratory study of the FACSCount system.

Authors:  A Lopez; I Caragol; J Candeias; N Villamor; P Echaniz; F Ortuño; A Sempere; K Strauss; A Orfao
Journal:  Cytometry       Date:  1999-10-15

2.  Single- versus dual-platform assays for human CD34+ cell enumeration.

Authors:  I L Barbosa; M E Sousa; M I Godinho; F Sousa; A Carvalhais
Journal:  Cytometry       Date:  1999-12-15

3.  Absolute CD4+ T-lymphocyte and CD34+ stem cell counts by single-platform flow cytometry: the way forward.

Authors:  D Barnett; V Granger; L Whitby; I Storie; J T Reilly
Journal:  Br J Haematol       Date:  1999-09       Impact factor: 6.998

4.  Effect of type of haematology analyser on CD4 count.

Authors:  G Robinson; L Morgan; M Evans; S McDermott; S Pereira; M Wansbrough-Jones; G Griffin
Journal:  Lancet       Date:  1992-08-22       Impact factor: 79.321

5.  Measuring percent lymphocytes by flow cytometry to calculate absolute lymphocyte subset counts for HIV+ specimens.

Authors:  H B Gale; K Henry
Journal:  Cytometry       Date:  1992

6.  Guidelines for the enumeration of CD4+ T lymphocytes in immunosuppressed individuals. CD4+ T lymphocyte Working Party. Members of the General Haematology Task Force of BCSH.

Authors: 
Journal:  Clin Lab Haematol       Date:  1997-12

7.  Performance evaluation of the FACSCount System: a dedicated system for clinical cellular analysis.

Authors:  K Strauss; I Hannet; S Engels; A Shiba; D M Ward; S Ullery; M G Jinguji; J Valinsky; D Barnett; A Orfao; L Kestens
Journal:  Cytometry       Date:  1996-03-15

8.  CD4+ T cell enumeration in HIV infection with limited resources.

Authors:  G G Sherman; J S Galpin; J M Patel; B V Mendelow; D K Glencross
Journal:  J Immunol Methods       Date:  1999-01-01       Impact factor: 2.303

Review 9.  CD4+ lymphocyte cell enumeration for prediction of clinical course of human immunodeficiency virus disease: a review.

Authors:  D S Stein; J A Korvick; S H Vermund
Journal:  J Infect Dis       Date:  1992-02       Impact factor: 5.226

10.  Immunophenotyping specimens from HIV-infected persons: laboratory guidelines from the Centers for Disease Control and Prevention.

Authors:  J K Nicholson
Journal:  Cytometry       Date:  1994-03-15
  10 in total
  6 in total

1.  ISHAGE-based single-platform flowcytometric analysis for measurement of absolute viable T cells in fresh or cryopreserved products: CD34/CD133 selected or CD3/CD19 depleted stem cells, DLI and purified CD56+CD3- NK cells.

Authors:  U Koehl; K Bochennek; R Esser; A Brinkmann; R Quaritsch; M Becker; J Soerensen; P Bader; D Schwabe; T Klingebiel; J Fischer; S Y Zimmermann
Journal:  Int J Hematol       Date:  2007-12-18       Impact factor: 2.490

2.  Clinical significance of 5-(and 6)-carboxyfluorescein diacetate succinimidyl ester-labeled microspheres for detecting endothelial progenitor cells in human peripheral blood.

Authors:  Chaolin Qiu; Denghai Zhang; Yongbin Chi; Qing Chen; Limin Xu; Qiuhua Xie
Journal:  Exp Ther Med       Date:  2017-06-23       Impact factor: 2.447

3.  HSP90 inhibitor, celastrol, arrests human monocytic leukemia cell U937 at G0/G1 in thiol-containing agents reversible way.

Authors:  Bin Peng; Limin Xu; Fanfan Cao; Tingxuan Wei; Chunxin Yang; Georges Uzan; Denghai Zhang
Journal:  Mol Cancer       Date:  2010-04-16       Impact factor: 27.401

4.  Celastrol inhibits lung infiltration in differential syndrome animal models by reducing TNF-α and ICAM-1 levels while preserving differentiation in ATRA-induced acute promyelocytic leukemia cells.

Authors:  Li-min Xu; Yue-juan Zheng; Ying Wang; Yang Yang; Fan-fan Cao; Bin Peng; Xiong-fei Xu; Hua-zhang An; Ao-xiang Zheng; Deng-hai Zhang; Georges Uzan; Yi-zhi Yu
Journal:  PLoS One       Date:  2014-08-12       Impact factor: 3.240

5.  Inhibiting inducible miR-223 further reduces viable cells in human cancer cell lines MCF-7 and PC3 treated by celastrol.

Authors:  Lu Cao; Xue Zhang; Fanfan Cao; Ying Wang; Yufan Shen; Chunxin Yang; Georges Uzan; Bin Peng; Denghai Zhang
Journal:  BMC Cancer       Date:  2015-11-09       Impact factor: 4.430

6.  Peptide deformylase inhibitor actinonin reduces celastrol's HSP70 induction while synergizing proliferation inhibition in tumor cells.

Authors:  Bin Peng; Xue Zhang; Fanfan Cao; Ying Wang; Limin Xu; Lu Cao; Chunxin Yang; Maoquan Li; Georges Uzan; Denghai Zhang
Journal:  BMC Cancer       Date:  2014-03-04       Impact factor: 4.430

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.